WHO ICTRP trial
The maximum tolerated dose of walking for people with osteoarthritis of the…
ACTRN12614000098639 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12614000098639 |
|---|---|
| Public title | The maximum tolerated dose of walking for people with osteoarthritis of the knee: a phase I trial |
| Scientific title | Determining the maximum tolerated dose of prescribed physical activity (in the form of walking) for people with severe osteoarthritis of the knee in the community in terms of safety and feasibility |
| Primary sponsor | Jason Wallis |
| Secondary sponsors | Nicholas Taylor;Kate Webster;Pazit Levinger;Chris Fong;Parminder Singh |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 1 |
| Countries | Australia |
| Conditions | knee osteoarthritis; knee osteoarthritis;Musculoskeletal - Osteoarthritis;Physical Medicine / Rehabilitation - Physiotherapy |
| Interventions | This is a phase I dose-response trial to find out how much physical activity, in the form of walking, can be prescribed for people with knee osteoarthritis in terms of safety and feasibility. Groups of 3 participants will be individually… |
| Registration date | Jan 28, 2014 |
| Target size | 45 |
| Secondary IDs | Nil |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: